1. Home
  2. SRI vs RNAC Comparison

SRI vs RNAC Comparison

Compare SRI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$7.22

Market Cap

205.4M

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.69

Market Cap

238.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
RNAC
Founded
1965
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.4M
238.9M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
SRI
RNAC
Price
$7.22
$8.69
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$16.00
$34.00
AVG Volume (30 Days)
104.5K
101.9K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
$2,797,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$4.60
$5.60
52 Week High
$9.71
$11.00

Technical Indicators

Market Signals
Indicator
SRI
RNAC
Relative Strength Index (RSI) 52.55 44.45
Support Level $7.26 $8.80
Resistance Level $7.51 $9.27
Average True Range (ATR) 0.23 0.62
MACD 0.03 -0.14
Stochastic Oscillator 71.01 11.64

Price Performance

Historical Comparison
SRI
RNAC

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Share on Social Networks: